BeOne Medicines Up Nearly 6%, on Pace for Largest Percent Increase Since November 2025 — Data Talk
BeOne Medicines Ltd. Sponsored ADR (ONC) is currently at $372.12, up $20.64 or 5.87%
--Would be highest close since Aug. 27, 2026, when it closed at $372.49
--On pace for largest percent increase since Nov. 12, 2025, when it rose 9.84%
--Currently up two consecutive days; up 6.6% over this period
--Best two-day stretch since the two days ending Aug. 10, 2026, when it rose 8.85%
--Up 1.69% month-to-date
--Up 22.48% year-to-date
--Down 7.7% from its all-time closing high of $403.14 on Sept. 17, 2021
--Up 17.01% from 52 weeks ago (Oct. 16, 2025), when it closed at $318.02
--Down 1.42% from its 52-week closing high of $377.47 on Nov. 12, 2025
--Up 42.97% from its 52-week closing low of $260.27 on June 11, 2026
--Traded as high as $373.24; highest intraday level since Sept. 30, 2026, when it hit $376.50
--Up 6.19% at today's intraday high; largest intraday percent increase since May 6, 2026, when it rose as much as 6.43%
All data as of 1:42:47 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 15, 2026 13:59 ET (17:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
United States